SEC Form 4 · accession 0001209191-18-050120
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
VENROCK ASSOCIATES IV L P
10% Owner
Nimish P Shah
10% Owner
VHCP Management III, LLC
10% Owner
VHCP Co-Investment Holdings III, LLC
10% Owner
Period of report
Sep 5, 2018
Accepted (ET)
Sep 7, 2018 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 5, 2018 | P | 50,000 | $0.8465 | A | 6,591,163 | I | By funds |
| Common StockF2 | Sep 6, 2018 | P | 50,000 | $0.8419 | A | 6,641,163 | I | By funds |
| Common StockF3 | Sep 7, 2018 | P | 60,000 | $0.8957 | A | 6,701,163 | I | By funds |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is the second of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons.
- F2Consists of (i) 45,455 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 4,545 shares purchased by VHCP Co-Investment Holdings III, LLC.
- F3Consists of (i) 54,546 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 5,454 shares purchased by VHCP Co-Investment Holdings III, LLC.